Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H M Scott

Showing results (11-20 of 116) with videos related to

Pageof 12
Sort By:
Pharmacoeconomics|November 3, 1997
Application of the findings of the European Stroke Prevention Study 2 (ESPS-2) to a New Zealand ischaemic stroke cost analysisG Scott, H M Scott
Biochimica Et Biophysica Acta|July 26, 1991
Pentamidine activates T1 the hepatic microsomal glucose 6-phosphate transport protein of the glucose-6-phosphatase systemH M Scott, A Burchell
Journal of Medical Education|September 1, 1973
Evaluation of clinical competence through a study of patient recordsH M Scott, A Sniderman
Zoonoses and Public Health|April 24, 2015
Reducing antimicrobial usage in agriculture and aquaculture: beyond regulatory policyJaap A Wagenaar, H M Scott
Pharmacoeconomics|November 4, 1993
Annual costs of benign prostatic hyperplasia in New ZealandW G Scott, H M Scott
The Journal of Nutrition|March 1, 1970
Estimates on the availability of amino acids in soybean oil meal as determined by chick growth assay: methodology as applied to lysineS P Netke, H M Scott
Pharmacoeconomics|December 9, 1995
Economic evaluation of vaccination against influenza in New ZealandW G Scott, H M Scott
Pharmacoeconomics|July 7, 1994
Critical leg ischaemia in New Zealand: economic cost of amputation versus intravenous iloprostH M Scott, W G Scott
The New Zealand Medical Journal|October 27, 1995
Hysterectomy for nonmalignant conditions: cost to New Zealand societyH M Scott, W G Scott
Pharmacoeconomics|January 8, 1996
Heart failure. A decision analytic analysis of New Zealand data using the published results of the SOLVD Treatment Trial. Studies of Left Ventricular DysfunctionW G Scott, H M Scott
Pageof 12

Showing results (11-20 of 116) with videos related to

Sort By:
Pageof 12
Pharmacoeconomics|November 3, 1997
Application of the findings of the European Stroke Prevention Study 2 (ESPS-2) to a New Zealand ischaemic stroke cost analysisG Scott, H M Scott
Biochimica Et Biophysica Acta|July 26, 1991
Pentamidine activates T1 the hepatic microsomal glucose 6-phosphate transport protein of the glucose-6-phosphatase systemH M Scott, A Burchell
Journal of Medical Education|September 1, 1973
Evaluation of clinical competence through a study of patient recordsH M Scott, A Sniderman
Zoonoses and Public Health|April 24, 2015
Reducing antimicrobial usage in agriculture and aquaculture: beyond regulatory policyJaap A Wagenaar, H M Scott
Pharmacoeconomics|November 4, 1993
Annual costs of benign prostatic hyperplasia in New ZealandW G Scott, H M Scott
The Journal of Nutrition|March 1, 1970
Estimates on the availability of amino acids in soybean oil meal as determined by chick growth assay: methodology as applied to lysineS P Netke, H M Scott
Pharmacoeconomics|December 9, 1995
Economic evaluation of vaccination against influenza in New ZealandW G Scott, H M Scott
Pharmacoeconomics|July 7, 1994
Critical leg ischaemia in New Zealand: economic cost of amputation versus intravenous iloprostH M Scott, W G Scott
The New Zealand Medical Journal|October 27, 1995
Hysterectomy for nonmalignant conditions: cost to New Zealand societyH M Scott, W G Scott
Pharmacoeconomics|January 8, 1996
Heart failure. A decision analytic analysis of New Zealand data using the published results of the SOLVD Treatment Trial. Studies of Left Ventricular DysfunctionW G Scott, H M Scott
Pageof 12